Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Lilia-Celine Lozada's Stock Ratings
JP Morgan Analyst
Lilia-Celine Lozada is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
20.9%
Smart Score
Overall Average Return Percentile
77th
Number of Ratings
8
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/16/2025 | NVST | Buy Now | Envista Holdings | $21.85 | 0.69% | $20 → $22 | Maintains | Neutral | Get Alert | |
| 12/16/2025 | ATRC | Buy Now | AtriCure | $41.10 | 16.79% | $42 → $48 | Maintains | Overweight | Get Alert | |
| 11/07/2025 | XRAY | Buy Now | Dentsply Sirona | $11.36 | 5.63% | $14 → $12 | Maintains | Neutral | Get Alert | |
| 11/07/2025 | TMCI | Buy Now | Treace Medical Concepts | $2.77 | 80.51% | $8 → $5 | Downgrade | Neutral → Underweight | Get Alert | |
| 03/27/2025 | ATRC | Buy Now | AtriCure | $41.10 | 11.92% | $51 → $46 | Maintains | Overweight | Get Alert | |
| 02/11/2025 | ATRC | Buy Now | AtriCure | $41.10 | 24.09% | $40 → $51 | Maintains | Overweight | Get Alert | |
| 12/17/2024 | TMCI | Buy Now | Treace Medical Concepts | $2.77 | 188.81% | → $8 | Assumes | → Neutral | Get Alert | |
| 12/17/2024 | ATRC | Buy Now | AtriCure | $41.10 | -2.68% | → $40 | Assumes | → Overweight | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved